Abstract
Objective: A placebo-controlled randomized crossover study to investigate the effects of zolpidem
on sleep stability in Japanese insomniac patients was performed using the cyclic alternating
pattern (CAP) rate, a polysomnographic marker that reflects sleep instability.
Methods: Seventeen patients (5 M and 12 F, mean age: 40.4±13.6 years) who met the International
Classification of Sleep Disorders (ICSD) criteria for psychophysiological insomnia
were evaluated. During the first period, patients were administered the placebo on
the first night, followed by either zolpidem or the placebo on the second night (treatment
night). The second crossover period was conducted after a minimum 3-day observation.
Improvement in the overnight CAP rate was the primary endpoint. Secondary endpoints
included the CAP variables, conventional sleep variables, EEG arousals, subjective
evaluation of sleep quality (measured by means of a visual analogue scale and the
St. Mary's Hospital Sleep Questionnaire), and drug safety.
Results: Zolpidem significantly decreased the overnight CAP rate values (57.6 vs. 39.0%, p=0.009)
and improved “sleep depth” (p=0.044) and “sleep quality” (p=0.023) subjective questionnaire
scores. Zolpidem also significantly improved VAS (p=0.036). The amount of time spent
in sleep stages 3+4 was significantly increased by zolpidem without affecting the
amounts of stage 2 and rapid eye movement (REM) sleep. Significant negative correlations
were found when the sleep quality score was matched to the CAP rate (p=0.022). No
serious adverse events occurred during the study.
Discussion: In Japanese patients with psychophysiological insomnia, zolpidem increased sleep
stability by significantly improving the overnight CAP rate. Zolpidem also improved
sleep depth and sleep quality, both subjectively and objectively.
References
1
ASDA (American Sleep Disorders Association). EEG arousals: scoring rules and examples
.
A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep
Disorders Association.
Sleep.
1992;
15
174-184
2
Cluydts R, Heyde K, DeVolder I.
Polysomnographic findings during non-continuous administration of zolpidem.
Sleep Med Rev.
2002;
6
S13-S19
3
Ellis BW, Johns MW, Lancaster R, Raptopoulos P, Angelopoulos N, Pariest RG.
The St. Mary's Hospital Sleep Questionnaire: A study of reliability.
Sleep.
1981;
4
93-97
4
Ferri R, Brumi O, Miano S, Terzano MG.
Topographic mapping of the spectral components of the cyclic alternating pattern (CAP).
Sleep Med.
2005;
6
29-36
5
Kudo Y, Shimada O, Kuroguchi Y, Kudo T, Suzuki H, Nakamura Y, Maeda Y.
Phase I study of zolpidem - single and multiple dose studies (in Japanese).
Rinsho Iyaku.
1990;
6
651-675
6
Nakajima T, Sasaki T, Nakagome K. et al .
Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency
in the morning: A cross-over study in healthy young volunteers.
Life Sci.
2000;
67
81-90
7
Parrino L, Boselli M, Spaggiari MC, Smerieri A, Terzano MG.
Multidrug comparison (Lorazepam, Triazolam, Zolpidem, and Zopiclone) in situational
insomnia: Polysomnographic analysis by means of the cyclic alternating pattern.
Clin Neuropharmacol.
1997;
20
253-263
8
Parrino L, Thomas RJ, Smerieri A, Spaggiari MC, Del Felice A, Terzano MG.
Reorganization of sleep patterns in severe OSAS under prolonged CPAP treatment.
Clin Neurophysiol.
2005;
116
2228-2239
9
Rechtschaffen A, Kales A.
A manual of standardized terminology, techniques and scoring system for sleep stages
of human subjects.
, University of California at Los Angeles, Los Angeles: Brain Information Service/Brain
Research Institute
10
Terzano MG, Mancia D, Salati MR, Costani G, Decembrino A, Parrino L.
The cyclic alternating pattern as a physiologic component of normal NREM sleep.
Sleep.
1985;
8
137-145
11
Terzano MG, Parrino L.
Clinical applications of cyclic alternating pattern.
Physiol Behav.
1993;
54
807-813
12
Terzano MG, Parrino L.
Effect of hypnotic drugs on sleep architecture.
Pol J Pharmacol.
1994;
46
487-490
13
Terzano MG, Parrino L.
Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls
under placebo and acute treatment with zolpidem.
Sleep.
1992;
15
64-70
14
Terzano MG, Parrino L.
Origin and significance of the cyclic alternating pattern (CAP).
[Review Article] Sleep Med Rev.
2000;
4
101-123
15
Terzano MG, Parrino L, Boselli M, Dell’Orso S, Moroni M, Spaggiari MC.
Changes of cyclic alternating pattern (CAP) parameters in situational insomnia under
brotizolam and triazolam.
Psychopharmacology (Berl).
1995;
120
237-243
16
Terzano MG, Parrino L, Boselli M, Smerieri A, Spaggiari MC.
CAP components and EEG synchronization in the first 3 sleep cycles.
Clin Neurophysiol.
2000;
111
283-290
17
Terzano MG, Parrino L, Boselli M, Spaggiari MC, Giovanni GD, Smerieri A.
Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: A 5-week study
evaluating zolpidem in insomniac patients.
Clin Neuropharmacol.
1997;
20
447-454
18
Terzano MG, Parrino L, Sherieri A, Chervin R, Chokroverty S, Guilleminault C, Hirshkowitz M,
Mahowald M, Moldfsky H, Rosa A, Thomas R, Walters A.
Atlas, rules, and recording techniques for the scoring of cyclic alternating pattern
(CAP) in human sleep.
Sleep Med.
2001;
2
537-553
19
Terzano MG, Parrino L, Spaggiari MC, Palomba V, Rossi M, Smerieri A.
CAP variables and arousals as sleep electroencephalogram markers for primary insomnia.
Clin Neurophysiol.
2003;
114
1715-1723
20
Thomas RJ, Terzano MG, Parrino L, Weiss JW.
Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern
- a recognizable polysomnographic variant with practical clinical implications.
Sleep.
2004;
27
229-234
21
Uchimura N, Nakajima T, Hayashi K. et al .
Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac
patients: A randomized crossover comparative study with brotizolam.
Prog Neuropsychopharmacol Biol Psychiatry.
2006;
30
22-29
22
Yagi T, Ozone M, Chiba S. et al .
Investigation of sleep stability using cyclic alternating pattern (CAP) - comparison
between patients with psychological insomnia and healthy sleepers in Japan.
[in Japanese] Insomnia research.
2006;
13-20
Correspondence
M. Ozone
Department of Psychiatry
Jikei University School of Medicine
3-25-8 Nishi-Shimbashi
Minato-ku
Tokyo 105-8461
Japan
Phone: +81/3/3433 11 11 ext: 33 01
Fax: +81/3/3437 02 28
Email: ozone@jikei.ac.jp